Pegcetacoplan Long Term Safety and Efficacy Extension Study
Clinical trial NCT03531255 · COMPLETED
Trial details
- NCT number
- NCT03531255
- Sponsor
- Apellis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-27
- Primary completion
- 2025-09-04
- Enrollment
- 137
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.